SCHEMBL7242736

SCHEMBL7242736

N#Cc1cc(-c2cccnc2)nn1-c1ccc(NCc2ccc(OCCCC3OCCO3)nc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 2/20 0.36
DYRK1A Q13627 2/20 0.36
CYP3A4 P08684 10/20 0.36
CYP2C9 P11712 9/20 0.36
CYP2C19 P33261 9/20 0.36
EPHX2 P34913 5/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
MCL1 Q07820 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP1A2 P05177 8/20 0.35
CYP2D6 P10635 5/20 0.35
CYP19A1 P11511 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7232820 0.87 ALDH1A1 (0.39) CYP3A4CYP2C9CYP2C19EPHX2KDM4E
SCHEMBL7240172 0.86 EPHX2 (0.48) EPHX2MAPTCYP11B1CYP11B2ABL1
SCHEMBL5205222 0.81 EPHX2 (0.48) EPHX2MAPTABL1PDGFRB
SCHEMBL7233535 0.78 CACNA1B (0.42) CYP3A4CYP2C9CYP2C19EPHX2KDM4E
SCHEMBL7092382 0.77 ITK (0.31)
SCHEMBL7244223 0.74 KDM4E (0.35) KDM4EMAPT
SCHEMBL7235236 0.73 EPHX2 (0.52) EPHX2MAPTABL1PDGFRB
SCHEMBL7630028 0.71 ABCB1 (0.36) DYRK1ACYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL7243350 0.71 ALDH1A1 (0.46) CYP3A4CYP2C9CYP2C19EPHX2KDM4E
SCHEMBL15070258 0.71 KDM4E (0.46) CYP3A4CYP2C9CYP2C19EPHX2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506747-B1 Method of treating an inflammatory disease which comprises administering to a patient in need of such treatment-a N-(4-(5-Ethyl-3-pyridin-3-yl-pyrazol-1-yl)phenyl)pyridine-3-carboxamide; BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2003-01-14 US claimed